Concepedia

Michael Ho

MH

Statistics

Publications

3

Citations

159

H-Index

3

Active since

1997

Affiliations

New Frontier(Current)

Molecular Discovery (United Kingdom)

Michael Ho is an author at New Frontier specializing in pharmacology, pharmacodynamics, and receptor pharmacology.

Publications per year

1997–2000

3

Publications

3

[<sup>3</sup>H]‐SB‐269970 – A selective antagonist radioligand for 5‐HT<sub>7</sub> receptors

David R. Thomas, Peter J. Atkinson, Michael Ho et al. · British Journal of Pharmacology · 2000 · 71 citations · Full text

, , +15

Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM<sub>1</sub>, hM<sub>2</sub>, hM<sub>3</sub>, hM<sub>4</sub> and hM<sub>5</sub> using microphysiometry

Martyn Wood, Karen L. Murkitt, Michael Ho et al. · British Journal of Pharmacology · 1999 · 64 citations · Full text

, , +14

(+)‐WAY 100135, a partial agonist, at native and recombinant 5‐HT<sub>1B/1D</sub> receptors

Colin Davidson, Michael Ho, Gary Price et al. · British Journal of Pharmacology · 1997 · 24 citations

, , +17

1–3 of 3